XMS:CA:TSX-iShares Edge MSCI Min Vol USA CAD Hedged (CAD)

ETF | US Equity |

Last Closing

CAD 37.81

Change

+0.13 (+0.35)%

Market Cap

N/A

Volume

1.10K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

-1.54 (-1.12%)

CAD 17.23B
ZSP:CA BMO S&P 500

-0.96 (-1.13%)

CAD 16.16B
XSP:CA iShares Core S&P 500 (CAD Hedg..

-0.51 (-0.85%)

CAD 10.90B
VUN:CA Vanguard US Total Market

-1.29 (-1.24%)

CAD 9.56B
XUS:CA iShares Core S&P 500 Index ETF

-0.56 (-1.16%)

CAD 7.36B
HXS:CA Global X S&P 500 Corporate Cla..

-0.95 (-1.19%)

CAD 4.06B
VSP:CA Vanguard S&P 500 CAD hedged

-0.84 (-0.90%)

CAD 3.52B
QUU:CA Mackenzie US Large Cap Equity ..

-2.53 (-1.13%)

CAD 3.25B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

-0.64 (-1.27%)

CAD 3.07B
XUU:CA iShares Core S&P US Total Mark..

-0.71 (-1.24%)

CAD 3.07B

ETFs Containing XMS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.16% 31% F 67% D+
Dividend Return 0.99% 55% F 30% F
Total Return 17.15% 33% F 65% D
Trailing 12 Months  
Capital Gain 25.61% 31% F 66% D+
Dividend Return 1.54% 59% D- 31% F
Total Return 27.16% 29% F 65% D
Trailing 5 Years  
Capital Gain 35.67% 25% F 60% D-
Dividend Return 5.85% 25% F 19% F
Total Return 41.52% 20% F 56% F
Average Annual (5 Year Horizon)  
Capital Gain 6.00% N/A N/A 59% D-
Dividend Return 7.11% N/A N/A 57% F
Total Return 1.12% N/A N/A 38% F
Risk Return Profile  
Volatility (Standard Deviation) 10.55% N/A N/A 81% B-
Risk Adjusted Return 67.43% N/A N/A 82% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike